Pregnancy and Birth

Recent research highlighted an association between the total dose of prescribed opioids during pregnancy and the heightened risk of spontaneous preterm birth, emphasizing the need for judicious opioid use in pain management for expectant mothers.

A cohort analysis suggests autism may be poorly diagnosed among expectant mothers—and linked to poor birth outcomes.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A comprehensive study reveals variations in monitoring low-risk cesarean delivery rates across 5 metrics, emphasizing the significance of timely and accurate assessment from birth certificate data.

A recent study revealed vaginal progesterone offers no significant reduction in preterm birth risk for twin gestations, prompting reconsideration of its proposed efficacy.

A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.

A recent study unveils a pragmatic model, incorporating factors such as insulin requirements, preeclampsia, and maternal age, to effectively predict primary cesarean delivery risk in pregnancies complicated by gestational diabetes mellitus.

A 755% increase in reported cases since 2012 highlights the need for timely testing and treatment to prevent maternal and infant health risks.

A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.

In a recent study, rates of urinary and anal incontinence were similar among patients receiving instructions for moderate vs intensive pushing for the active phase of second stage labor.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent study, models for embryo evaluation using artificial intelligence had strong accuracy.

In a recent study, women with an interpregnancy interval under 3 months, more often had worse pregnancy outcomes compared to those with an interval of 3 to under 6 months or of 6 to 12 months.

In a recent study, physical abnormalities were seen among children born from pregnancies complicated by fentanyl.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent study, pregnant women in South Korea were not at an increased risk of early abortive outcomes from COVID-19 vaccination and had increased protection against COVID-19.

In a recent study, patients with a higher maternal comorbidity score were at an increased risk of cesarean delivery.

In a recent study, opioid prescriptions were decreased among patients receiving a noninvasive bioelectronic treatment after cesarean delivery.

In a recent study, visual biofeedback of the introitus during pushing was more well-received by patients than viewing of the maternal face.

A targeted, collaborative approach to reduce length of stay (LOS) after cesarean or vaginal delivery resulted in a significant and sustained decrease in mean postpartum LOS without compromising patient safety, according to a poster featured at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting, held in Chicago, Illinois.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent study, adverse maternal and child outcomes associated with maternal postnatal depression were reduced by selective serotonin reuptake inhibitor use.

The Vaginal Birth After Cesarean (VBAC) Calculator will be available as a standalone tool and as a part of the VBAC counseling plans and Scheduling for Repeat Cesarean plans.

In a recent study, multiple misleading claims were found on websites selling direct-to-consumer Anti-Mullerian hormone tests.

In a recent study, adherence to diets was associated with pregnancy loss outcomes after infertility treatment.

Approved for use at 32 weeks through 36 weeks gestation, Pfizer’s maternal respiratory syncytial vaccine (Abrysvo), is delivered through a single dose injection to the muscle, and is the first vaccine for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD because of RSV in infants (birth to 6 months).

In a recent study, rates of infant mortality were lowest among patients who delivered at 39 weeks of gestation.

In a recent study, temporal trends indicated a rise in induction at 39 weeks of gestation and decrease in cesarean delivery among low-risk nulliparous patients in the United States.

In a recent study, COVID-19 infection was common in mothers who experienced stillbirth or late miscarriage.

In a recent study, only blood pressure levels considered stage 2 hypertension were useful for predicting adverse pregnancy outcomes.